脱毛症（抜け毛治療）の世界市場成長 2024-2030

Global Alopecia (Hair Loss Treatment) Market Growth 2024-2030

LPI（LPインフォメーション）の最新調査によると、世界の脱毛症（抜け毛治療）市場規模は2023年に8億5600万米ドルとなった。下流市場での需要拡大に伴い、脱毛症（抜け毛治療）は2030年までに1億342.4百万米ドル... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
LP Information LPインフォメーション	2024年2月7日	US$3,660 シングルユーザライセンスライセンス・価格情報注文方法はこちら	155	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

LPI（LPインフォメーション）の最新調査によると、世界の脱毛症（抜け毛治療）市場規模は2023年に8億5600万米ドルとなった。下流市場での需要拡大に伴い、脱毛症（抜け毛治療）は2030年までに1億342.4百万米ドルの再調整規模になると予測され、レビュー期間中のCAGRは6.6%である。
この調査レポートは、世界の脱毛症（抜け毛治療）市場の成長可能性を明らかにしています。脱毛症（抜け毛治療）は今後の市場で安定した成長を示すと予想される。しかし、脱毛症（抜け毛治療）の普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場プレーヤーは、脱毛症（抜け毛治療）市場がもたらす莫大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを築き、進化する消費者の嗜好に合わせた製品を提供する必要がある。
脱毛症は、頭皮だけでなく全身に影響を及ぼす可能性があり、一時的なものから永久的なものまである。遺伝、ホルモンの変化、医学的状態、あるいは加齢の正常な部分が原因となることもある。頭髪は誰でも抜ける可能性がありますが、男性に多く見られます。
世界の医薬品市場は、2022年には1,475億米ドルとなり、今後6年間のCAGRは5％で成長する。医薬品市場には化学医薬品と生物学的製剤がある。生物製剤は2022年に3810億ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間＆政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が公衆衛生の新たなニーズに機敏に対応する必要性をさらに強調している。
主な特徴
脱毛症（抜け毛治療）市場に関する本レポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。
市場規模と成長：この調査レポートは、脱毛症（抜け毛治療）市場の現在の規模と成長の概要を提供します。過去データ、タイプ別市場区分（例：シャンプー＆コンディショナー、医薬品）、地域別内訳を含む場合があります。
市場促進要因と課題：政府規制、環境問題、技術の進歩、消費者の嗜好の変化など、脱毛症（抜け毛治療）市場の成長を促進する要因を特定・分析することができます。また、インフラストラクチャーの制限、射程距離への不安、高額な初期費用など、業界が直面する課題も浮き彫りにすることができます。
競合情勢：この調査レポートは、脱毛症（抜け毛治療）市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれています。また、新興プレーヤーとその潜在的な市場への影響もハイライトできます。
技術開発：調査レポートは、脱毛症（抜け毛治療）業界における最新の技術開発を掘り下げることができます。これには、脱毛症（抜け毛治療）技術の進歩、脱毛症（抜け毛治療）新規参入企業、脱毛症（抜け毛治療）新規投資、脱毛症（抜け毛治療）の将来を形作るその他の技術革新が含まれます。
川下の事業者の好み：本レポートは、脱毛症（抜け毛治療）市場における顧客の購買行動や採用動向に光を当てることができます。顧客の購買決定、脱毛症（抜け毛治療）製品の嗜好に影響を与える要因も含まれる。
政府の政策とインセンティブ調査レポートは、政府の政策やインセンティブが脱毛症（抜け毛治療）市場に与える影響を分析します。これには、脱毛症（抜け毛治療）市場の促進を目的とした規制枠組み、補助金、税制優遇措置などの評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価する。
環境への影響と持続可能性調査レポートは、脱毛症（抜け毛治療）市場の環境への影響と持続可能性の側面を評価します。
市場予測と将来展望：実施した分析に基づき、調査レポートは脱毛症（抜け毛治療）産業の市場予測と展望を提供します。これには、市場規模、成長率、地域別動向、技術進歩や政策展開に関する予測などが含まれます。
提言と機会本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、脱毛症（抜け毛治療）市場の成長と発展に貢献するための潜在的な機会を強調しています。
市場の細分化
脱毛症（抜け毛治療）市場は、タイプ別と用途別に分けられます。2019年から2030年までの期間について、セグメント間の成長により、タイプ別、用途別の消費額の正確な計算と予測を数量と金額で提供します。
タイプ別セグメント
シャンプー＆コンディショナー
医薬品
用途別セグメント
男性用
女性
本レポートでは、市場を地域別にも分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
資生堂
ロート製薬
ユニリーバ
大正
アンファー
ロレアル
カミノモト
メルク
柳屋本店
アモーレパシフィック
プロクター・アンド・ギャンブル
ヒマラヤ
ジェロリマトス・インターナショナル
メルツ・ファーマ
リーダーテック
ヴァスヘルスケア
VLCC
アレス・グループ
山西アンテ
万盛製薬
アドバンスド・スキン＆ヘア
ヒューマンウェルヘルスケア
トップボンド
ライフス2グッド
バワン
YNK製薬
アポロ
ジンシュータン
ロゲイン
マリコ
本レポートで扱う主な質問
世界の脱毛症（抜け毛治療）市場の10年間の見通しは？
世界および地域別に、脱毛症（抜け毛治療）市場の成長を促進する要因は何か？
市場別、地域別に最も急成長する技術は何か？
脱毛症（抜け毛治療）市場の機会は最終市場規模によってどのように異なるのか？
脱毛症（抜け毛治療）のタイプ別、用途別内訳は？

ページTOPに戻る

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alopecia (Hair Loss Treatment) Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Alopecia (Hair Loss Treatment) by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Alopecia (Hair Loss Treatment) by Country/Region, 2019, 2023 & 2030
2.2 Alopecia (Hair Loss Treatment) Segment by Type
2.2.1 Shampoos and Conditioners
2.2.2 Medicine Product
2.3 Alopecia (Hair Loss Treatment) Sales by Type
2.3.1 Global Alopecia (Hair Loss Treatment) Sales Market Share by Type (2019-2024)
2.3.2 Global Alopecia (Hair Loss Treatment) Revenue and Market Share by Type (2019-2024)
2.3.3 Global Alopecia (Hair Loss Treatment) Sale Price by Type (2019-2024)
2.4 Alopecia (Hair Loss Treatment) Segment by Application
2.4.1 Men
2.4.2 Women
2.5 Alopecia (Hair Loss Treatment) Sales by Application
2.5.1 Global Alopecia (Hair Loss Treatment) Sale Market Share by Application (2019-2024)
2.5.2 Global Alopecia (Hair Loss Treatment) Revenue and Market Share by Application (2019-2024)
2.5.3 Global Alopecia (Hair Loss Treatment) Sale Price by Application (2019-2024)
3 Global Alopecia (Hair Loss Treatment) by Company
3.1 Global Alopecia (Hair Loss Treatment) Breakdown Data by Company
3.1.1 Global Alopecia (Hair Loss Treatment) Annual Sales by Company (2019-2024)
3.1.2 Global Alopecia (Hair Loss Treatment) Sales Market Share by Company (2019-2024)
3.2 Global Alopecia (Hair Loss Treatment) Annual Revenue by Company (2019-2024)
3.2.1 Global Alopecia (Hair Loss Treatment) Revenue by Company (2019-2024)
3.2.2 Global Alopecia (Hair Loss Treatment) Revenue Market Share by Company (2019-2024)
3.3 Global Alopecia (Hair Loss Treatment) Sale Price by Company
3.4 Key Manufacturers Alopecia (Hair Loss Treatment) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alopecia (Hair Loss Treatment) Product Location Distribution
3.4.2 Players Alopecia (Hair Loss Treatment) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alopecia (Hair Loss Treatment) by Geographic Region
4.1 World Historic Alopecia (Hair Loss Treatment) Market Size by Geographic Region (2019-2024)
4.1.1 Global Alopecia (Hair Loss Treatment) Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Alopecia (Hair Loss Treatment) Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Alopecia (Hair Loss Treatment) Market Size by Country/Region (2019-2024)
4.2.1 Global Alopecia (Hair Loss Treatment) Annual Sales by Country/Region (2019-2024)
4.2.2 Global Alopecia (Hair Loss Treatment) Annual Revenue by Country/Region (2019-2024)
4.3 Americas Alopecia (Hair Loss Treatment) Sales Growth
4.4 APAC Alopecia (Hair Loss Treatment) Sales Growth
4.5 Europe Alopecia (Hair Loss Treatment) Sales Growth
4.6 Middle East & Africa Alopecia (Hair Loss Treatment) Sales Growth
5 Americas
5.1 Americas Alopecia (Hair Loss Treatment) Sales by Country
5.1.1 Americas Alopecia (Hair Loss Treatment) Sales by Country (2019-2024)
5.1.2 Americas Alopecia (Hair Loss Treatment) Revenue by Country (2019-2024)
5.2 Americas Alopecia (Hair Loss Treatment) Sales by Type
5.3 Americas Alopecia (Hair Loss Treatment) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alopecia (Hair Loss Treatment) Sales by Region
6.1.1 APAC Alopecia (Hair Loss Treatment) Sales by Region (2019-2024)
6.1.2 APAC Alopecia (Hair Loss Treatment) Revenue by Region (2019-2024)
6.2 APAC Alopecia (Hair Loss Treatment) Sales by Type
6.3 APAC Alopecia (Hair Loss Treatment) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alopecia (Hair Loss Treatment) by Country
7.1.1 Europe Alopecia (Hair Loss Treatment) Sales by Country (2019-2024)
7.1.2 Europe Alopecia (Hair Loss Treatment) Revenue by Country (2019-2024)
7.2 Europe Alopecia (Hair Loss Treatment) Sales by Type
7.3 Europe Alopecia (Hair Loss Treatment) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alopecia (Hair Loss Treatment) by Country
8.1.1 Middle East & Africa Alopecia (Hair Loss Treatment) Sales by Country (2019-2024)
8.1.2 Middle East & Africa Alopecia (Hair Loss Treatment) Revenue by Country (2019-2024)
8.2 Middle East & Africa Alopecia (Hair Loss Treatment) Sales by Type
8.3 Middle East & Africa Alopecia (Hair Loss Treatment) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alopecia (Hair Loss Treatment)
10.3 Manufacturing Process Analysis of Alopecia (Hair Loss Treatment)
10.4 Industry Chain Structure of Alopecia (Hair Loss Treatment)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alopecia (Hair Loss Treatment) Distributors
11.3 Alopecia (Hair Loss Treatment) Customer
12 World Forecast Review for Alopecia (Hair Loss Treatment) by Geographic Region
12.1 Global Alopecia (Hair Loss Treatment) Market Size Forecast by Region
12.1.1 Global Alopecia (Hair Loss Treatment) Forecast by Region (2025-2030)
12.1.2 Global Alopecia (Hair Loss Treatment) Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alopecia (Hair Loss Treatment) Forecast by Type
12.7 Global Alopecia (Hair Loss Treatment) Forecast by Application
13 Key Players Analysis
13.1 Shiseido
13.1.1 Shiseido Company Information
13.1.2 Shiseido Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.1.3 Shiseido Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Shiseido Main Business Overview
13.1.5 Shiseido Latest Developments
13.2 Rohto
13.2.1 Rohto Company Information
13.2.2 Rohto Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.2.3 Rohto Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Rohto Main Business Overview
13.2.5 Rohto Latest Developments
13.3 Unilever
13.3.1 Unilever Company Information
13.3.2 Unilever Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.3.3 Unilever Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Unilever Main Business Overview
13.3.5 Unilever Latest Developments
13.4 Taisho
13.4.1 Taisho Company Information
13.4.2 Taisho Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.4.3 Taisho Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Taisho Main Business Overview
13.4.5 Taisho Latest Developments
13.5 Angfa
13.5.1 Angfa Company Information
13.5.2 Angfa Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.5.3 Angfa Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Angfa Main Business Overview
13.5.5 Angfa Latest Developments
13.6 LOreal
13.6.1 LOreal Company Information
13.6.2 LOreal Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.6.3 LOreal Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 LOreal Main Business Overview
13.6.5 LOreal Latest Developments
13.7 Kaminomoto
13.7.1 Kaminomoto Company Information
13.7.2 Kaminomoto Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.7.3 Kaminomoto Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Kaminomoto Main Business Overview
13.7.5 Kaminomoto Latest Developments
13.8 Merck
13.8.1 Merck Company Information
13.8.2 Merck Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.8.3 Merck Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Merck Main Business Overview
13.8.5 Merck Latest Developments
13.9 Yanagiya Honten
13.9.1 Yanagiya Honten Company Information
13.9.2 Yanagiya Honten Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.9.3 Yanagiya Honten Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Yanagiya Honten Main Business Overview
13.9.5 Yanagiya Honten Latest Developments
13.10 Amorepacific
13.10.1 Amorepacific Company Information
13.10.2 Amorepacific Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.10.3 Amorepacific Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Amorepacific Main Business Overview
13.10.5 Amorepacific Latest Developments
13.11 Procter & Gamble
13.11.1 Procter & Gamble Company Information
13.11.2 Procter & Gamble Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.11.3 Procter & Gamble Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Procter & Gamble Main Business Overview
13.11.5 Procter & Gamble Latest Developments
13.12 Himalaya
13.12.1 Himalaya Company Information
13.12.2 Himalaya Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.12.3 Himalaya Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Himalaya Main Business Overview
13.12.5 Himalaya Latest Developments
13.13 Gerolymatos International
13.13.1 Gerolymatos International Company Information
13.13.2 Gerolymatos International Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.13.3 Gerolymatos International Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Gerolymatos International Main Business Overview
13.13.5 Gerolymatos International Latest Developments
13.14 Merz Pharma
13.14.1 Merz Pharma Company Information
13.14.2 Merz Pharma Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.14.3 Merz Pharma Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Merz Pharma Main Business Overview
13.14.5 Merz Pharma Latest Developments
13.15 Leader Teck
13.15.1 Leader Teck Company Information
13.15.2 Leader Teck Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.15.3 Leader Teck Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Leader Teck Main Business Overview
13.15.5 Leader Teck Latest Developments
13.16 Vasu Healthcare
13.16.1 Vasu Healthcare Company Information
13.16.2 Vasu Healthcare Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.16.3 Vasu Healthcare Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Vasu Healthcare Main Business Overview
13.16.5 Vasu Healthcare Latest Developments
13.17 VLCC
13.17.1 VLCC Company Information
13.17.2 VLCC Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.17.3 VLCC Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 VLCC Main Business Overview
13.17.5 VLCC Latest Developments
13.18 Ales Group
13.18.1 Ales Group Company Information
13.18.2 Ales Group Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.18.3 Ales Group Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Ales Group Main Business Overview
13.18.5 Ales Group Latest Developments
13.19 Shanxi Ante
13.19.1 Shanxi Ante Company Information
13.19.2 Shanxi Ante Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.19.3 Shanxi Ante Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Shanxi Ante Main Business Overview
13.19.5 Shanxi Ante Latest Developments
13.20 Wansheng Pharmaceutical
13.20.1 Wansheng Pharmaceutical Company Information
13.20.2 Wansheng Pharmaceutical Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.20.3 Wansheng Pharmaceutical Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.20.4 Wansheng Pharmaceutical Main Business Overview
13.20.5 Wansheng Pharmaceutical Latest Developments
13.21 Advanced Skin and Hair
13.21.1 Advanced Skin and Hair Company Information
13.21.2 Advanced Skin and Hair Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.21.3 Advanced Skin and Hair Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.21.4 Advanced Skin and Hair Main Business Overview
13.21.5 Advanced Skin and Hair Latest Developments
13.22 Humanwell Healthcare
13.22.1 Humanwell Healthcare Company Information
13.22.2 Humanwell Healthcare Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.22.3 Humanwell Healthcare Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.22.4 Humanwell Healthcare Main Business Overview
13.22.5 Humanwell Healthcare Latest Developments
13.23 Topfond
13.23.1 Topfond Company Information
13.23.2 Topfond Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.23.3 Topfond Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.23.4 Topfond Main Business Overview
13.23.5 Topfond Latest Developments
13.24 Lifes2good
13.24.1 Lifes2good Company Information
13.24.2 Lifes2good Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.24.3 Lifes2good Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.24.4 Lifes2good Main Business Overview
13.24.5 Lifes2good Latest Developments
13.25 Bawang
13.25.1 Bawang Company Information
13.25.2 Bawang Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.25.3 Bawang Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.25.4 Bawang Main Business Overview
13.25.5 Bawang Latest Developments
13.26 YNK Pharmaceutical
13.26.1 YNK Pharmaceutical Company Information
13.26.2 YNK Pharmaceutical Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.26.3 YNK Pharmaceutical Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.26.4 YNK Pharmaceutical Main Business Overview
13.26.5 YNK Pharmaceutical Latest Developments
13.27 Apollo
13.27.1 Apollo Company Information
13.27.2 Apollo Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.27.3 Apollo Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.27.4 Apollo Main Business Overview
13.27.5 Apollo Latest Developments
13.28 Jingxiutang
13.28.1 Jingxiutang Company Information
13.28.2 Jingxiutang Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.28.3 Jingxiutang Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.28.4 Jingxiutang Main Business Overview
13.28.5 Jingxiutang Latest Developments
13.29 Rogaine
13.29.1 Rogaine Company Information
13.29.2 Rogaine Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.29.3 Rogaine Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.29.4 Rogaine Main Business Overview
13.29.5 Rogaine Latest Developments
13.30 Marico
13.30.1 Marico Company Information
13.30.2 Marico Alopecia (Hair Loss Treatment) Product Portfolios and Specifications
13.30.3 Marico Alopecia (Hair Loss Treatment) Sales, Revenue, Price and Gross Margin (2019-2024)
13.30.4 Marico Main Business Overview
13.30.5 Marico Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

Table of Contents

Summary

According to our LPI (LP Information) latest study, the global Alopecia (Hair Loss Treatment) market size was valued at US$ 856 million in 2023. With growing demand in downstream market, the Alopecia (Hair Loss Treatment) is forecast to a readjusted size of US$ 1342.4 million by 2030 with a CAGR of 6.6% during review period.
The research report highlights the growth potential of the global Alopecia (Hair Loss Treatment) market. Alopecia (Hair Loss Treatment) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Alopecia (Hair Loss Treatment). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Alopecia (Hair Loss Treatment) market.
Hair loss (alopecia) can affect just your scalp or your entire body, and it can be temporary or permanent. It can be the result of heredity, hormonal changes, medical conditions or a normal part of aging. Anyone can lose hair on their head, but it's more common in men.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Alopecia (Hair Loss Treatment) market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Alopecia (Hair Loss Treatment) market. It may include historical data, market segmentation by Type (e.g., Shampoos and Conditioners, Medicine Product), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Alopecia (Hair Loss Treatment) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Alopecia (Hair Loss Treatment) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Alopecia (Hair Loss Treatment) industry. This include advancements in Alopecia (Hair Loss Treatment) technology, Alopecia (Hair Loss Treatment) new entrants, Alopecia (Hair Loss Treatment) new investment, and other innovations that are shaping the future of Alopecia (Hair Loss Treatment).
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Alopecia (Hair Loss Treatment) market. It includes factors influencing customer ' purchasing decisions, preferences for Alopecia (Hair Loss Treatment) product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Alopecia (Hair Loss Treatment) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Alopecia (Hair Loss Treatment) market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Alopecia (Hair Loss Treatment) market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Alopecia (Hair Loss Treatment) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Alopecia (Hair Loss Treatment) market.
Market Segmentation:
Alopecia (Hair Loss Treatment) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
Shampoos and Conditioners
Medicine Product
Segmentation by application
Men
Women
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Shiseido
Rohto
Unilever
Taisho
Angfa
LOreal
Kaminomoto
Merck
Yanagiya Honten
Amorepacific
Procter & Gamble
Himalaya
Gerolymatos International
Merz Pharma
Leader Teck
Vasu Healthcare
VLCC
Ales Group
Shanxi Ante
Wansheng Pharmaceutical
Advanced Skin and Hair
Humanwell Healthcare
Topfond
Lifes2good
Bawang
YNK Pharmaceutical
Apollo
Jingxiutang
Rogaine
Marico
Key Questions Addressed in this Report
What is the 10-year outlook for the global Alopecia (Hair Loss Treatment) market?
What factors are driving Alopecia (Hair Loss Treatment) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alopecia (Hair Loss Treatment) market opportunities vary by end market size?
How does Alopecia (Hair Loss Treatment) break out type, application?

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（消費財）の最新刊レポート

LP Information社の消費財分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問

LP Information社はどのような調査会社ですか?

LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

脱毛症（抜け毛治療）の世界市場成長 2024-2030

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（消費財）の最新刊レポート

LP Information社の消費財分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

よくあるご質問

LP Information社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?